Proteomic survey of the pathogenic Mycoplasma hyopneumoniae strain 7448 and identification of novel post-translationally modified and antigenic proteins

https://doi.org/10.1016/j.vetmic.2006.11.018Get rights and content

Abstract

Mycoplasma hyopneumoniae is an important pathogen for pigs, being the causative agent of enzootic pneumonia. Recently, the genome sequences of three strains, J, 7448 and 232 have been reported. Here, we describe the results of a proteomic analysis, based on two-dimensional gel electrophoresis of soluble protein extracts, immunoblot and mass spectrometry, which was carried out aiming the identification of gene products and antigenic proteins from the M. hyopneumoniae pathogenic strain 7448. A preliminary M. hyopneumoniae proteome map in two pH ranges (3–10 and 4–7) was produced. A total of 31 different coding DNA sequences (CDSs), including three hypothetical ones, were experimentally verified with the identification of the corresponding protein products by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. According to the Clusters of Orthologous Groups (COG) functional classification, the identified proteins were assigned to the groups of metabolism (13), cellular processes (5) and information and storage processing (4). Nine of the identified proteins were not classifiable by COG, including some related to cytoadherence and possibly involved in pathogenicity. Moreover, at least five highly antigenic proteins of M. hyopneumoniae were identified by immunoblots, including four novel ones (a heat shock protein 70, an elongation factor Tu, a pyruvate dehydrogenase E1-beta subunit and the P76 membrane protein). The now available proteome map is expected to serve as a reference for comparative analyses between M. hyopneumoniae pathogenic and non-pathogenic strains, and for methabolic studies based on cells cultured under modified conditions.

Introduction

Mycoplasma hyopneumoniae is highly infective for swines and is the causative agent of enzootic pneumonia (EP), a disease characterized by sporadic, dry and non-productive cough, retarded growth and inefficient food conversion (Maes et al., 1996). EP is responsible for major economical losses in pig industry. Despite presenting low direct mortality rates, it causes increased susceptibility to secondary respiratory infections, due to the M. hyopneumoniae-associated deactivation of mucociliary functions.

There have been several efforts to identify and characterize M. hyopneumoniae antigens (see, for example, Subramaniam et al., 2000, Yang et al., 2005, Castro et al., 2006, Chen et al., 2006, Conceição et al., 2006, Meens et al., 2006). The recently published genome sequences of three M. hyopneumoniae strains, two pathogenic (232 and 7448) and one non-pathogenic (J) (Minion et al., 2004, Vasconcelos et al., 2005), will contribute to such efforts, accelerating the process of identification of novel antigenic proteins. These antigens, besides being potentially useful for immunodiagnosis and/or vaccination, may be relevant as virulence factors (Wassenaar and Gaastra, 2001, Ferreira and Castro, 2007), and their characterization may help to elucidade mechanisms of pathogenicity. Regarding immunodiagnosis, there is an obvious need for better antigens, in order to improve the serological methods currently used for pig herd surveying, an important step prior to preventive or therapeutical measures (Thacker, 2004, Kim et al., 2006, Lorenzo et al., 2006).

A proteomics approach based on two-dimensional gel electrophoresis (2DE), mass spectrometry (MS) and genomic data is a powerful tool for genome expression profiling. Proteome analysis has proven to be useful for bacteria, as a complementary method to support genome annotation and protein identification (Ueberle et al., 2002, Jaffe et al., 2004), and to characterize antigenic, differentially expressed or post-translationally modified proteins (Lebeau et al., 2005). 2DE mapping of M. hyopneumoniae proteins will improve genome annotation and help to characterize the extent of post-translational modifications and to identify potential virulence factors.

In this work, a preliminary 2DE map of M. hyopneumoniae is described and the repertoire of proteins identified by tandem MS is discussed. Moreover, we identified novel antigenic proteins from the M. hyopneumoniae pathogenic strain 7448 with potential for use in diagnosis.

Section snippets

Bacterial strain, cultivation and cell extracts

M. hyopneumoniae strain 7448 was isolated from an infected swine in Lindóia do Sul, Santa Catarina, Brazil. When inoculated in specific pathogen free (SPF) pigs, this strain caused disease and consistently produced the characteristic symptoms of EP (Vasconcelos et al., 2005). Isolation and cultivation were performed in standard conditions, as described by Friis (1975), with cells grown in 2 l of medium, until a density corresponding to 108 CFU ml−1. Cells were harvested by centrifugation at 18,000 ×

Two-dimensional electrophoresis

In order to resolve the prominent proteins of M. hyopneumoniae 7448, we performed 2DE from protein extracts from bacteria grown for 21 days in standard culture conditions. As technical controls, all protein preparations and subsequent 2DE were repeated three times, with a very high degree of reproducibility (data not shown).

About 350 prominent proteins spots were resolved in Coomassie stained 2DE gels with pH 3–10 IPG (IPG 3–10) strips (Fig. 1A), with molecular weights ranging from 18 to 216 

Discussion

We described a preliminary proteome map of the M. hyopneumoniae pathogenic strain 7448, whose entire genome sequence has been recently reported (Vasconcelos et al., 2005). The 2DE allowed the resolution of more than 350 protein spots in the pH range of 3–10, and 280 protein spots in the pH range of 4–10, corresponding to a coverage of more than 50 and 30%, respectively, of the 671 predicted protein gene products from the M. hyopneumoniae 7448 genome, even considering that some different spots

Acknowledgements

We thank Dr. Fabio C. Gozzo, for the help with the MS analysis, Marni Ramenzoni and Suzana S. Kuchiishi, for the support in M. hyopneumoniae cultivation, and Dr. Augusto Schrank, for the critical reading of this manuscript. P.M.P. is a recipient of a CNPq predoctoral fellowship; L.A.C. was a recipient of a CAPES predoctoral fellowship; G.C. was a recipient of a CAPES post-doctoral fellowship; and A.P.M.C. is a recipient of a CNPq ITI fellowship. This work was supported by funding from MCT/CNPq,

References (42)

  • W.J. Yang et al.

    Epitope mapping of Mycoplasma hyopneumoniae using phage displayed peptide libraries and the immune responses of the selected phagotopes

    J. Immunol. Methods

    (2005)
  • L.G. Almeida et al.

    A system for automated bacterial (genome) integrated annotation—SABIA

    Bioinformatics

    (2004)
  • T.A. Burnett et al.

    P159 is a proteolytically processed, surface adhesin of Mycoplasma hyopneumoniae: defined domains of P159 bind heparin and promote adherence to eukaryote cells

    Mol. Microbiol.

    (2006)
  • L. Brocchieri et al.

    Protein length in eukaryotic and prokaryotic proteomes

    Nucleic Acids Res.

    (2005)
  • A.Y. Chen et al.

    Evaluation of the immunogenicity of the P97R1 adhesin of Mycoplasma hyopneumoniae as a mucosal vaccine in mice

    J. Med. Microbiol.

    (2006)
  • S.F. Dallo et al.

    Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae

    Mol. Microbiol.

    (2002)
  • P. De Berardinis et al.

    New recombinant vaccines based on the use of prokaryotic antigen-display systems

    Expert Rev. Vaccines

    (2004)
  • S.P. Djordjevic et al.

    Proteolytic processing of the Mycoplasma hyopneumoniae cilium adhesin

    Infect. Immun.

    (2004)
  • Ferreira, H.B., Castro, L.A., 2007. A preliminary survey of Mycoplasma hyopneumoniae virulence factors based on...
  • M. Ferrer-Navarro et al.

    Proteome of the bacterium Mycoplasma penetrans

    J. Proteome Res.

    (2006)
  • N.F. Friis

    Some recommendations concerning primary isolation of Mycoplasma suipneumoniae and Mycoplasma flocculare. A survey

    Nord. Vet. med.

    (1975)
  • Cited by (57)

    • Evidences of differential endoproteolytic processing on the surfaces of Mycoplasma hyopneumoniae and Mycoplasma flocculare

      2020, Microbial Pathogenesis
      Citation Excerpt :

      However, the extant of this adhesin processing in terms of the numbers of targeted proteins, and generated proteoforms remains elusive. So far, proteolytic processing has been assessed for several adhesins and adhesion-related proteins, and for some other surface proteins, as well [10–23]. These studies have been carried out mostly in the M. hyopneumoniae 232 (pathogenic) and J (non-pathogenic) strains, but not in comparative approaches.

    • Secretomes of Mycoplasma hyopneumoniae and Mycoplasma flocculare reveal differences associated to pathogenesis

      2017, Journal of Proteomics
      Citation Excerpt :

      These results suggest that major differences between M. hyopneumoniae and M. flocculare could be determined at post-transcriptional level, including qualitative and quantitative differences in protein repertoires expressed by these bacteria. Pioneering M. hyopneumoniae proteomics studies have been carried out by our group, assessing both intracellular [6,7] and surface proteins [8]. The comparative proteomic analysis between M. hyopneumoniae pathogenic and non-pathogenic strains [7] showed that pathogenic strains present constitutive expression of adhesins, which prompt the bacterial cells for adhesion and infection prior to host contact, and proteolytic cleavage of adhesins prior to their secretion to the cell surface, diversifying the bacterial surface protein repertoire (the ‘unsoluble secretome’, [9]).

    • Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines

      2017, Heliyon
      Citation Excerpt :

      Further studies, however, are still needed in order to better evaluate their abilities to carry and deliver different recombinant polypeptides to vaccinated animals. In the search for antigens suitable for use in anti-PEP subunit vaccines, the M. hyopneumoniae heat shock protein of 70 kDa (HSP70) has been shown to be antigenic and recognized by sera from M. hyopneumoniae-infected swine [22]. Moreover, a recombinant version of an extracellular antigenic domain of HSP70 combined with Freund’s adjuvant demonstrated promising results in eliciting both humoral and cellular specific responses [9].

    View all citing articles on Scopus
    View full text